World's Best Scientists 2026 revealed!
Marco M. Gottardis

Marco M. Gottardis

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
11313
World Ranking
13872
National Ranking
5865

Marco M. Gottardis publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Marco M. Gottardis sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 260 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Marco M. Gottardis D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Marco M. Gottardis sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Marco M. Gottardis is affiliated with NKGen Biotech Inc in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a specific focus on Pulmonary and Respiratory Medicine, Molecular Biology, Immunology, Oncology, and Cancer Research.

The main topics addressed in their work include Prostate Cancer Treatment and Research, Ubiquitin and proteasome pathways, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cancer, Lipids, and Metabolism, Protein Degradation and Inhibitors, and Hormonal and reproductive studies.

Notable recent publications by Marco M. Gottardis include the following:

  • Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors, 2020, Cell chemical biology
  • Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer, 2021, Prostate Cancer and Prostatic Diseases
  • Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC), 2021, Journal of Medicinal Chemistry
  • Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor), 2023, Journal for ImmunoTherapy of Cancer
  • The discovery of BMS-737 as a potent, CYP17 lyase-selective inhibitor for the treatment of castration-resistant prostate cancer, 2022, Bioorganic & Medicinal Chemistry Letters

Frequent coauthors collaborating with Marco M. Gottardis include Jonathan R. Branch, Gilles Bignan, Ian Hickson, James R. Bischoff, and Brent Rupnow.

The scientist has published in several venues with multiple contributions to Cell chemical biology, Prostate Cancer and Prostatic Diseases, Journal of Medicinal Chemistry, Journal for ImmunoTherapy of Cancer, and Cancer Research Communications.

Best Publications

  • Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

    Jennifer H. Law;Golareh Habibi;Kaiji Hu;Hamid Masoudi

  • Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells.

    P. Garcia-Morales;M. Saceda;N. Kenney;N. Kim

  • BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR

    Joan M. Carboni;Mark Wittman;Zheng Yang;Francis Lee

  • Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes.

    Ruslan Novosyadlyy;Danielle E. Lann;Archana Vijayakumar;Anne Rowzee;Anne Rowzee

  • Decreased Egr‐1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation

    Ruo-Pan Huang;Yan Fan;Ian De Belle;Christina Niemeyer

  • Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail

    Hyun Jung Kim;Beate C. Litzenburger;Xiaojiang Cui;David A. Delgado

  • Chemoprevention of Mammary Carcinoma by LGD1069 (Targretin): An RXR-selective Ligand

    Marco M. Gottardis;Eric D. Bischoff;Michael A. Shirley;Murriel A. Wagoner

  • In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

    Paul Haluska;Joan M. Carboni;David A. Loegering;Francis Y. Lee

  • Castration-resistant prostate cancer: locking up the molecular escape routes.

    Ricardo M. Attar;Chris H. Takimoto;Marco M. Gottardis

  • Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor

    Joan M. Carboni;Adrian V. Lee;Darryl L. Hadsell;Bruce R. Rowley

  • Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen.

    Marco M. Gottardis;Simon P. Robinson;V.Craig Jordan

  • The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors.

    Fei Huang;Ann Greer;Warren Hurlburt;Xia Han

  • Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.

    Eric D. Bischoff;Marco M. Gottardis;Thomas E. Moon;Richard A. Heyman

  • Synergistic methods and compositions for treating cancer

    Joan M. Carboni;Warren W. Hurlburt;Marco M. Gottardis

  • Circumventing Tamoxifen Resistance in Breast Cancers Using Antiestrogens That Induce Unique Conformational Changes in the Estrogen Receptor

    Caroline E. Connor;John D. Norris;Gloria Broadwater;Timothy M. Willson

  • High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling

    Hind Medyouf;Samuel Gusscott;Hongfang Wang;Jen Chieh Tseng

  • Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity.

    Mark Wittman;Joan Carboni;Ricardo Attar;Balu Balasubramanian

  • The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens

    Liang Schweizer;Cheryl A Rizzo;Thomas E Spires;J Suso Platero

  • Drug safety is a barrier to the discovery and development of new androgen receptor antagonists

    William R. Foster;Bruce D. Car;Hong Shi;Paul C. Levesque

  • Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo

    S R Howe;M M Gottardis;J I Everitt;C Walker

Frequent Co-Authors

George L. Trainor
George L. Trainor Bristol-Myers Squibb (Germany)
Michael Pollak
Michael Pollak McGill University
Gary E. Gallick
Gary E. Gallick The University of Texas MD Anderson Cancer Center
Cheryl L. Walker
Cheryl L. Walker Baylor College of Medicine
John T. Hunt
John T. Hunt Bristol-Myers Squibb (Germany)
Hinrich Gronemeyer
Hinrich Gronemeyer Institute of Genetics and Molecular and Cellular Biology
Christopher J. Logothetis
Christopher J. Logothetis The University of Texas MD Anderson Cancer Center
Michael T. Lewis
Michael T. Lewis Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in advancing your career in Biology or Biochemistry, there are several flexible online pathways to consider. Many healthcare and science-related fields now offer accelerated and accessible online degree options, tailored to meet the needs of busy professionals and students.

For those looking to specialize in mental health nursing, the fastest pmhnp program options can help you quickly gain qualifications as a Psychiatric Mental Health Nurse Practitioner. Alternatively, those in nursing may choose the 12-month fnp program online to become a Family Nurse Practitioner in just one year.

If nutrition and wellness are your interests, explore an accelerated nutrition degree online to fast-track your entry into the dietetics field. Current registered nurses seeking advancement can benefit from the easiest rn to bsn online program, designed for ease of learning and speed of completion.

These diverse online programs offer a blend of flexibility and speed, making it easier than ever to pursue specialized careers linked to Biology, Biochemistry, and the health sciences.

Best Scientists Citing Marco M. Gottardis

Trending Scientists

Recently Published Articles